On 29 April, Anthony Fauci, director of the US National Institute of Allergy and Infectious Diseases (NIAID), announced that a clinical trial in more than 1,000 people had showed that those taking remdesivir recovered in 11 days on average, compared with 15 days for those on a placebo. There were also fewer deaths among trial participants who received the drug, he said, but that trend was not statistically significant. The shortened recovery time, however, was significant.
https://www.nature.com/articles/d41586-020-01295-8
The WHO guidelines: “This document describes certification and classification (coding) of deaths related to COVID-19. The primary goal is to identify all deaths due to COVID-19.” https://www.who.int/classifications/icd/Guidelines_Cause_of_Death_COVID-19.pdf The CDC (USA) guidelines: “The purpose of this report is to provide guidance… Continue Reading →